STACEY DOBBS: Open Payments
NPI 1750796082 · WARSAW, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 9 payments from 7 companies in 2025. Trend: 2023 $93 · 2024 $236 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $65 |
| Dexcom, Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Ardelyx, Inc. | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
Products named: VRAYLAR, Dexcom G6 Transmitter, UBRELVY, REXULTI, LEQVIO, AIRSUPRA, IBSRELA, The Cologuard Plus Collection Kit.
Industry payments across MO — which companies pay providers there.
